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**Abstract**

Functional magnetic resonance imaging (fMRI) studies have consistently pointed towards amygdala, medial prefrontal cortex and subgenual cortex/anterior cingulate as key structures in the circuit involved in depression. Early fMRI studies showed that sertraline intervention in depressive patients was associated with increased corticolimbic connectivity, thereby possibly increasing the regulatory influence of cortical mood-regulating regions over limbic regions (Anand et al, 2005). Pharmacological intervention with the selective serotonin reuptake inhibitor (SSRI) escitalopram results in a selective modulation of the intrinsic network connectivity associated with the medial prefrontal-limbic system (Wang et al, 2015). However, also non-pharmacological intervention with bright light exposure significantly affects amygdala-prefrontal reactivity and communication, an effect partly moderated by 5-HTTLPR genotype (Fisher et al, 2014). That is, the corticolimbic circuit is sensitive to both SSRI and to bright light intervention, supporting the relevance of these regions for mood disorders and the associated treatment.

Molecular brain imaging studies have, on the other hand, shown less regional specificity. Patients with seasonal affective disorder, investigated both in their symptom-free phase in the summer and in the winter when they had season-related depression, failed to down-regulate their cerebral sertonin transporter (5-HTT) binding globally, as opposed to individuals resilient to seasonal affective disorder. In healthy individuals, light therapy given in the winter was associated with 12% decreased 5-HTT binding in the anterior cingulate relative to placebo. And individuals at high familial risk for mood disorders had a 35% reduction in 5-HTT binding in dorsolateral prefrontal cortex and a tendency to reduction in anterior cingulate.

In conclusion, whereas several fMRI studies identify amygdala, medial prefrontal cortex and subgenual cortex/anterior cingulate as key structures, some molecular imaging studies of 5-HTT binding suggest that dorsolateral prefrontal cortex, anterior cingulate and the raphe regions are specifically involved, but with less certainty. The separate methodological challenges associated with these two non-invase imaging modalities will be discussed.
